Regulation of mature T lymphocyte proliferation and differentiation by Par-4
Open Access
- 15 September 2003
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 22 (18) , 4689-4698
- https://doi.org/10.1093/emboj/cdg460
Abstract
The genetic inactivation of the atypical protein kinase C (aPKC) inhibitor, Par‐4, gives rise to increased NF‐κB activation and decreased stimulation of JNK in embryo fibroblasts. Here we have characterized the immunological phenotype of the Par‐4−/− mice and found that the loss of this gene leads to an increased proliferative response of peripheral T cells when challenged through the TCR. This is accompanied by a higher increase in cell cycle entry and inhibition of apoptosis, with enhanced IL‐2 secretion but normal CD25 synthesis. Interestingly, the TCR‐triggered activation of NF‐κB was augmented and that of JNK was severely abrogated. Consistent with previous data from knock outs of different JNKs, NFATc1 activation and IL‐4 secretion were augmented in the Par‐4‐deficient CD4+ T cells, suggesting that the loss of Par‐4 drives T‐cell differentiation towards a Th2 response. This is compelling evidence that Par‐4 is a novel modulator of the immune response through its ability to impact aPKC activity, which translates into lower JNK signaling.Keywords
This publication has 23 references indexed in Scilit:
- Genetic inactivation of Par4 results in hyperactivation of NF‐κB and impairment of JNK and p38EMBO Reports, 2003
- NF‐κB activation by protein kinase C isoforms and B‐cell functionEMBO Reports, 2003
- Role of zetaPKC in B-cell signaling and functionThe EMBO Journal, 2002
- NFAT SignalingCell, 2002
- c-Jun NH2-Terminal Kinase (JNK)1 and JNK2 Signaling Pathways Have Divergent Roles in CD8+ T Cell–mediated Antiviral ImmunityThe Journal of Experimental Medicine, 2002
- c-Jun NH2-Terminal Kinase (JNK)1 and JNK2 Have Distinct Roles in CD8+ T Cell ActivationThe Journal of Experimental Medicine, 2002
- Endotoxin exposure in allergy and asthma: Reconciling a paradoxJournal of Allergy and Clinical Immunology, 2002
- Inhibition of JNK activation through NF-κB target genesNature, 2001
- Targeted Disruption of the ζPKC Gene Results in the Impairment of the NF-κB PathwayMolecular Cell, 2001
- Regulation of Nuclear Factor κB TransactivationJournal of Biological Chemistry, 2001